{"retracted":false,"update":{"timestamp":1436486400000,"doi":"10.1016/j.neulet.2015.05.042","type":"erratum"},"doi":"10.1016/j.neulet.2014.04.041","journal":"Neuroscience Letters","publisher":"Elsevier BV","title":"Corrigendum to “The amyloid-beta degradation pattern in plasma—A possible tool for clinical trials in Alzheimer’s disease” [Neurosci. Lett. 573 (2014) 7–12]"}
